logo

KwaZulu-Natal Research Institute for Tuberculosis and HIV, Durban

Sector: Advanced Electronics • Location: South Africa

Source: Pharmaceutical Technology

Project
Closed

KwaZulu-Natal Research Institute for Tuberculosis and HIV (K-RITH) is located in Durban, South Africa. K-RITH was founded in 2008 by the Howard Hughes Medical Institute (HHMI) and the University of KwaZulu-Natal (UKZN). Research facility Durban, South Africa July 2011 October 2012 40,000 square feet $40m Howard Hughes Medical Institute and the University of KwaZulu-Natal FGG Architects WBHO Constr

Project Information FAQ

Project Information

5 Q
The project “KwaZulu-Natal Research Institute for Tuberculosis and HIV, Durban” is an infrastructure initiative in the Advanced Electronics sector, located in South Africa. Taiyo aggregates data on it from Pharmaceutical Technology.

Want to explore the full details? View the full report

Participants

Sponsoring Agency

Obfuscated Data

Company

Obfuscated Data

Status

Original status

closed

Taiyo status

Obfuscated Data

Taiyo last update

00-00-0000

Available timestamps

00-00-0000

Available timestamp type

Obfuscated Data

Contact

Contact name

Obfuscated Data

Phone

0000000000

Email

ObfuscatedData@email.com

Address

Obfuscated Data, Obfuscated data, obfuscated data, Obfuscated data

Description

Description

KwaZulu-Natal Research Institute for Tuberculosis and HIV (K-RITH) is located in Durban, South Africa. K-RITH was founded in 2008 by the Howard Hughes Medical Institute (HHMI) and the University of KwaZulu-Natal (UKZN). Research facility Durban, South Africa July 2011 October 2012 40,000 square feet $40m Howard Hughes Medical Institute and the University of KwaZulu-Natal FGG Architects WBHO Construction KwaZulu-Natal Research Institute for Tuberculosis and HIV (K-RITH) is located in Durban, South Africa. K-RITH was founded in 2008 by the Howard Hughes Medical Institute (HHMI) and the University of KwaZulu-Natal (UKZN). It is part of the UKZN’s Nelson R. Mandela School of Medicine campus. The facility will carry out research on tuberculosis (TB) and HIV with the aim of developing innovative treatments for controlling these diseases. It was built with an investment of $40m. Groundbreaking for the state-of-the-art facility took place in July 2011. Its construction took more than a year to complete. It was officially inaugurated in October 2012. HIV cases reported in South Africa are the highest in the world, at 5.7 million. Nearly 15% of the HIV cases are reported in the KwaZulu-Natal Province. Incidence of TB in HIV patients has also increased in the region, with nearly 295 cases reported per 100,000 people. The new research facility is located in the heart of this HIV/TB affected region, enabling the institute to provide advanced laboratory facilities to the local population. The institute will include six to nine large scientific research groups focusing on five areas of research. These include development of efficient diagnostic tests for TB, identification of drug-resistant strains of TB, and analysing immune responses to TB. The research groups will also analyse the recurrent TB infections in HIV-infected patients and develop targeted treatments. K-RITH has partnered with the Max Planck Society to set up two research groups at the facility. It has also tied-up with several institutions in Africa, North America, Europe, and Asia to further expand its research. HHMI will provide $75m to K-RITH over 10 years for carrying out research. The Technology Innovation Agency has also made financial commitments to the institute’s activities. The facility covers 4,000m² (40,000ft²) spread over nine levels. A large glass atrium connects the facility with the Nelson R. Mandela school, and the Doris Duke Medical Research Institute. The institute has dedicated research centres for microbiology, immunology, pharmacology, high-throughput biology, and clinical protocol development. Three laboratories at the facility have Bio-containment level 3 (BSL3) laboratory modules. The entire seventh floor of the building is dedicated to BSL3 laboratory modules occupying 600m² (6,000ft²). These modules will be used for safe handling of HIV and the bacteria that causes TB and its strains. The BSL3 laboratory modules feature triple glazed windows. The containment levels in the BSL 3 laboratories are controlled by Phoenix constant flow / regulating valves. The valves, fitted to the air circulation system in the laboratories and adjacent rooms, control the flow of air and maintain the negative pressure in the zone served. The building has meeting facilities for large events, which can also be divided into smaller conference rooms. All systems in the facility will be fully recoverable and functional in case of a power outage. The Centre for the AIDS Programme of Research in South Africa (CAPRISA) and LifeLab also have offices in the building. Cipla Medpro Pharmaceuticals is listed on the Johannesburg Securities Exchange and is one of South Africa’s top ten and fastest-growing pharmaceutical groups. Sustainably sourced Ukume wood has been used in the construction of the building. A Building Management System (BMS) controls the lighting on all levels of the facility. The lighting is adjusted by the BMS in response to the occupancy levels. T5 lamp technology is used to for the lighting in the laboratory and office spaces. The technology maintains light-to-power ratio output, thereby ensuring a long lamp life. Levels two and three of the building feature sensors which switch off the lights in the absence of any occupants. FGG Architects were the architects for the building. The main contractor was WBHO Construction. Get industry leading news, data and analysis delivered to your inbox Give your business an edge with our leading industry insights.

Original sub-sector

Obfuscated

Original Currency

USD

Original budget

000000000000000

Procurement method

Obfuscated Data

Budget

000000000000000

Location

Region

Obfuscated

Country

Obfuscated

State

Obfuscated Data

County

Obfuscated

Location

Obfuscated Data, Obfuscated data, obfuscated data, Obfuscated data

Source

Source reliability

High

Data quality score

100%

Source

Obfuscated Data

URL

obfuscated_data,obfuscateddata.com

More Details

Project Type

Obfuscated Data

Article Published Date

Obfuscated Data